From: Cross-population analysis for functional characterization of type II diabetes variants
Populations | # Cases | # Controls | # Screened SNPs | # Significant tagSNPs | Significance Threshold (P-value) | # Significant tagSNPs + LD |
---|---|---|---|---|---|---|
British (W) | 1,999 | 1,504 | 495,477 | 482 | < 1e −5 | 1,831 |
American + European (D) | 1,007 | 983 | 561,656 | 350 | < 1e −8 | 1,686 |
Finnish (F) | 1,161 | 1,174 | 317,503 | 157 | < 5 x1e − 7 | 898 |
French (Fr) | 679 | 697 | 392,365 | 4 | < 7 × 1e −4 | 71 |
Saudi (S) | 2,207 | 2,276 | 48 | 41 | < 0.05 | 297 |
Korean (K) | 462 | 456 | 2,188,613 | 395 | < 1e −5 | 1,859 |
Japanese (J) | 23,399 | 31,722 | 7,521,072 | 211 | < 1e −8 | 668 |
Chinese (C) | 684 | 955 | 2,900,000 | 33 | < 2.6 x 1e−8 | 361 |
Lebanese (L) | 1,902 | 1,384 | 5,891,794 | 23 | < 1e −5 | 61 |